150 related articles for article (PubMed ID: 7518293)
21. [Nerve growth factor receptor (NGFR)-like immunoreactivity in the perineurial cells of the adult rat peripheral nerves: normal appearance and response to nerve section].
Yamamoto M; Iseki S
Kaibogaku Zasshi; 1992 Oct; 67(5):642-9. PubMed ID: 1462757
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous Malignant Peripheral Nerve Sheath Tumor.
Luzar B; Falconieri G
Surg Pathol Clin; 2017 Jun; 10(2):337-343. PubMed ID: 28477884
[TBL] [Abstract][Full Text] [Related]
23. Epithelial membrane antigen expression by the perineurial cell: further studies of peripheral nerve lesions.
Theaker JM; Fletcher CD
Histopathology; 1989 Jun; 14(6):581-92. PubMed ID: 2759555
[TBL] [Abstract][Full Text] [Related]
24. Expressions of nerve growth factor and p75 low affinity receptor after transient forebrain ischemia in gerbil hippocampal CA1 neurons.
Lee TH; Abe K; Kogure K; Itoyama Y
J Neurosci Res; 1995 Aug; 41(5):684-95. PubMed ID: 7563249
[TBL] [Abstract][Full Text] [Related]
25. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study.
Dou YC; Hagströmer L; Emtestam L; Johansson O
Arch Dermatol Res; 2006 Jun; 298(1):31-7. PubMed ID: 16586073
[TBL] [Abstract][Full Text] [Related]
26. Light and electron microscopic immunohistochemical observations of p75 nerve growth factor receptor-immunoreactive dermal nerves in prurigo nodularis.
Liang Y; Marcusson JA; Johansson O
Arch Dermatol Res; 1999 Jan; 291(1):14-21. PubMed ID: 10025723
[TBL] [Abstract][Full Text] [Related]
27. Glial fibrillary acidic protein (GFAP) immunoreactivity in peripheral nerve sheath tumors.
Memoli VA; Brown EF; Gould VE
Ultrastruct Pathol; 1984; 7(4):269-75. PubMed ID: 6543600
[TBL] [Abstract][Full Text] [Related]
28. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
[TBL] [Abstract][Full Text] [Related]
29. Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients.
Harder A; Wesemann M; Hagel C; Schittenhelm J; Fischer S; Tatagiba M; Nagel C; Jeibmann A; Bohring A; Mautner VF; Paulus W
Am J Surg Pathol; 2012 May; 36(5):702-9. PubMed ID: 22446939
[TBL] [Abstract][Full Text] [Related]
30. Expression of c-Jun and Sox-2 in human schwannomas and traumatic neuromas.
Shivane A; Parkinson DB; Ammoun S; Hanemann CO
Histopathology; 2013 Mar; 62(4):651-6. PubMed ID: 23362975
[TBL] [Abstract][Full Text] [Related]
31. trkB-like immunoreactivity in rat dorsal root ganglia following sciatic nerve injury.
Foster E; Robertson B; Fried K
Brain Res; 1994 Oct; 659(1-2):267-71. PubMed ID: 7820673
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
Friedrich RE; Beer C; Glatzel M; Hagel C
Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
[TBL] [Abstract][Full Text] [Related]
33. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Suo Z; Emilsen E; Tveit KM; Nesland JM
Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
[TBL] [Abstract][Full Text] [Related]
34. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
35. Expression of the ERBB2/neu and neurofibromatosis type 1 gene products in reactive and neoplastic schwann cell proliferation.
Schlegel J; Muenkel K; Trenkle T; Fauser G; Ruschoff J
Int J Oncol; 1998 Dec; 13(6):1281-4. PubMed ID: 9824645
[TBL] [Abstract][Full Text] [Related]
36. Nerve growth factor receptor (p75)-immunoreactivity in the normal adult feline trigeminal system and following retrogasserian rhizotomy.
Henry MA; Westrum LE; Bothwell M; Johnson LR
J Comp Neurol; 1993 Sep; 335(3):425-36. PubMed ID: 8227529
[TBL] [Abstract][Full Text] [Related]
37. Reexpression of nerve growth factor receptor in human traumatic injured spinal cord.
Wang Z; Gerhard L
Chin Med J (Engl); 1995 Jun; 108(6):438-43. PubMed ID: 7555254
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromatosis and malignant schwannomas in Tanzania.
Amir H; Moshi E; Kitinya JN
East Afr Med J; 1993 Oct; 70(10):650-3. PubMed ID: 8187663
[TBL] [Abstract][Full Text] [Related]
39. Nerve growth factor receptor immunoreactivity in human benign peripheral nerve sheath tumor.
Yasuda T; Sobue G; Mitsuma T; Takahashi A; Hashizume Y
Acta Neuropathol; 1989; 77(6):591-8. PubMed ID: 2546354
[TBL] [Abstract][Full Text] [Related]
40. Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors.
Johnson MD; Kamso-Pratt J; Federspiel CF; Whetsell WO
Arch Pathol Lab Med; 1989 Nov; 113(11):1263-70. PubMed ID: 2479359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
